Acquisitions20 Mar 2026, 01:39 pm
Anlon Healthcare Ltd Successfully Acquires 56.67% Stake in Bizotic Life Science Private Limited
AI Summary
Anlon Healthcare Ltd has completed the acquisition of 56.67% equity shareholding of Bizotic Life Science Private Limited on March 20, 2026. This acquisition makes Bizotic Life Science Private Limited a subsidiary of Anlon Healthcare Limited. The investment is in compliance with Section 179 (3) (e) & (j) and all other applicable provisions of Companies Act, 2013. The details of this acquisition were previously disclosed on November 28, 2025, in accordance with the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Key Highlights
- Anlon Healthcare Ltd acquires 56.67% stake in Bizotic Life Science Private Limited
- Bizotic Life Science Private Limited becomes a subsidiary of Anlon Healthcare Limited
- The acquisition is in compliance with Section 179 (3) (e) & (j) and all other applicable provisions of Companies Act, 2013
- The investment was previously disclosed on November 28, 2025
- The acquisition was completed on March 20, 2026